Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 5/20 | 0.69 |
| ▸ | PDE4B | Q07343 | 5/20 | 0.69 |
| ▸ | PDE4C | Q08493 | 5/20 | 0.69 |
| ▸ | PDE4D | Q08499 | 5/20 | 0.69 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.69 |
| ▸ | MEN1 | O00255 | 2/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.66 |
| ▸ | BRD4 | O60885 | 5/20 | 0.60 |
| ▸ | BRD2 | P25440 | 2/20 | 0.60 |
| ▸ | BRD3 | Q15059 | 2/20 | 0.60 |
| ▸ | BRDT | Q58F21 | 2/20 | 0.60 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | PKM | P14618 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27582971 | 0.87 | KDM4E (0.62) | PDE4APDE4BPDE4CPDE4DADORA2A | |
| SCHEMBL556874 | 0.85 | BRD4 (0.66) | PDE4APDE4BPDE4CPDE4DADORA2A | |
| SCHEMBL17682216 | 0.85 | SMN1; SMN2 (0.64) | PDE4APDE4BPDE4CPDE4DADORA2A | |
| SCHEMBL3902928 | 0.82 | PDE4A (1.00) | PDE4APDE4BPDE4CPDE4DADORA2A | |
| SCHEMBL9294863 | 0.80 | MEN1 (0.63) | PDE4APDE4BPDE4CPDE4DADORA2A | |
| SCHEMBL7457891 | 0.79 | MEN1 (1.00) | PDE4APDE4BPDE4CPDE4DADORA2A | |
| SCHEMBL21381257 | 0.78 | PDE4A (1.00) | PDE4APDE4BPDE4CPDE4DADORA2A | |
| SCHEMBL7464482 | 0.78 | PDE4A (0.86) | PDE4APDE4BPDE4CPDE4DADORA2A | |
| SCHEMBL11399596 | 0.77 | MEN1 (0.95) | PDE4APDE4BPDE4CPDE4DADORA2A | |
| SCHEMBL16058831 | 0.77 | MAPK1 (0.67) | PDE4APDE4BPDE4CPDE4DADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250386846-A1 | Food Compositions Including Aragonite | NANT HOLDINGS IP LLC (US) | 2025-12-25 | — | — | US | disclosed |
| US-12419336-B2 | Beverage compositions including calcium supplied from aragonite and methods of making the same | NANT HOLDINGS IP, LLC (US) | 2025-09-23 | — | — | US | disclosed |
| US-20250194654-A1 | Beverage Compositions Including Calcium Supplied From Aragonite And Methods Of Making The Same | NANT HOLDINGS IP, LLC | 2025-06-19 | — | — | US | disclosed |
| US-12310392-B2 | Beverage compositions including calcium supplied from aragonite and methods of making the same | NANT HOLDINGS IP, LLC (US) | 2025-05-27 | — | — | US | disclosed |
| US-20240381918-A1 | Beverage Compositions Including Calcium Supplied From Aragonite And Methods Of Making The Same | NANT HOLDINGS IP, LLC | 2024-11-21 | — | — | US | disclosed |
| US-12089621-B2 | Beverage compositions including calcium supplied from aragonite and methods of making the same | NANT HOLDINGS IP, LLC (US) | 2024-09-17 | — | — | US | disclosed |
| US-20230354865-A1 | Beverage Compositions Including Calcium Supplied From Aragonite And Methods Of Making The Same | NANT HOLDINGS IP, LLC | 2023-11-09 | — | — | US | disclosed |
| US-11793224-B2 | Beverage compositions including calcium supplied from aragonite and methods of making the same | NANT HOLDINGS IP, LLC (US) | 2023-10-24 | — | — | US | disclosed |
| US-20230085907-A1 | Beverage Compositions Including Calcium Supplied From Aragonite And Methods Of Making The Same | NANT HOLDINGS IP, LLC | 2023-03-23 | — | — | US | disclosed |
| US-11533940-B2 | Beverage compositions including calcium supplied from aragonite and methods of making the same | NANT HOLDINGS IP, LLC (US) | 2022-12-27 | — | — | US | disclosed |
| US-6703056-B2 | .01-10% OF ARABINOGALACTAN, AND ZINC, IRON, MAGNESIUM, CALCIUM, SELENIUM, IODINE, OR FLUORINE | THE PROCTER + GAMBLE CO. | 2004-03-09 | — | — | US | disclosed |
| US-6616955-B2 | Free of milk base solids; especially fruit juice | THE PROCTOR & GAMBLE CO. | 2003-09-09 | — | — | US | disclosed |
| EP-1196050-B1 | COMPOSITIONS FOR PROVIDING AND MAINTAINING ENERGY AND MENTAL ALERTNESS | PROCTER & GAMBLE (US) | 2003-04-23 | — | — | EP | disclosed |
| US-20030069202-A1 | Compositions, kits, and methods for promoting defined health benefits | PROCTER & GAMBLE COMPANY, THE | 2003-04-10 | — | — | US | disclosed |
| US-20020187219-A1 | Low glycemic response compositions | THE PROCTER & GAMBLE CO. | 2002-12-12 | — | — | US | disclosed |
| US-20020136802-A1 | Beverage compositions comprising arabinogalactan and defined minerals | THE PROCTER & GAMBLE CO. | 2002-09-26 | — | — | US | disclosed |
| US-20020132780-A1 | Low carbohydrate compositions, kits thereof, and methods of use | SD IP HOLDINGS COMPANY | 2002-09-19 | — | — | US | disclosed |
| US-20020122847-A1 | Beverage compositions comprising palatable calcium and magnesium sources | PROCTER & GAMBLE COMPANY, THE | 2002-09-05 | — | — | US | disclosed |
| US-20020110632-A1 | Beverage compositions comprising arabinogalactan and defined vitamins | THE PROCTER & GAMBLE CO. | 2002-08-15 | — | — | US | disclosed |
| US-6413558-B1 | MIXTURE OF MONOSACCHARIDES, DISACCHARIDES AND MALTODEXTRIN | THE PROCTOR & GAMBLE CO. | 2002-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250386846-A1 | Food Compositions Including Aragonite | PLCG2, PLCG1, PLCB3 | PDE4A 3601/4885PDE4B 3149/4885PDE4C 2886/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.